Abstract
Previous studies proved that AS-IV could prevent blood-brain barrier (BBB) against an increase in permeability. However, its underlying molecular mechanism has not been enlightened yet. The aim of the study is to reveal the potential protective mechanism of astragaloside IV (AS-IV) on the blood-brain barrier after ischemia-reperfusion. In vivo, AS-IV neurological protection was measured by Long's five-point scale and 2,3,5-triphenyltetrazolium chloride staining. AS-IV protection for BBB was observed by Evans blue extravasation technique. Endoplasmic reticulum stress and apoptosis-related protein levels were measured by western blot with AS-IV intervention. In vitro, cell apoptosis was analyzed by western blot and flow cytometry.Endoplasmic reticulum stress-related protein levels were quantified through western blot. AS-IV treatment could decrease the infarct size in rats' brain and protect the BBB against Evans blue permeating through brain, after ischemia/reperfusion, significantly. Further, ischemia/reperfusion or oxygen-glucose deprivation/reperfusion was found to have an increase in endothelial cell apoptosis proteins, such as Bax, Bcl-2, and caspase-3, and endoplasmic reticulum stress-associated proteins, such as phosphory...Continue Reading
References
Jan 1, 1989·Stroke; a Journal of Cerebral Circulation·E Z LongaR Cummins
Apr 13, 2010·Molecular and Cellular Biochemistry·Shiyun DongWei-Hua Zhang
Feb 19, 2011·Nature Reviews. Neuroscience·Edward A NeuweltLester R Drewes
Oct 4, 2012·Neurology·Rakesh KhatriVallabh Janardhan
Jul 12, 2014·Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology·Yifang ChenNiansong Wang
Mar 22, 2015·International Journal of Cardiology·Min WangXiao-Bo Sun
Jan 13, 2017·Journal of Clinical Neurology·Simone VidaleDomenico Consoli
Apr 18, 2017·Experimental and Therapeutic Medicine·Miao ChenHai-Rong Wang
Aug 2, 2017·Scientific Reports·Hengjiang GuoWen Peng
Aug 28, 2017·European Journal of Pharmacology·Ningning CuiQiuyue Yan
Nov 21, 2017·Experimental Cell Research·Wenjing ChenChunyan Zhang
Jan 3, 2018·Toxicology and Applied Pharmacology·Hongli LiXiaojun Wu
Jun 28, 2018·American Journal of Physiology. Cell Physiology·Wazir AbdullahiPatrick T Ronaldson
Sep 27, 2018·Nature Neuroscience·Melanie D SweeneyBerislav V Zlokovic
Oct 3, 2018·Journal of Cellular Biochemistry·Yi ZhangHongxia Xing
Nov 6, 2018·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Yinghui JuWeiping Li
Mar 7, 2019·Frontiers in Cellular Neuroscience·Huy TranKalpna Gupta
May 16, 2019·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Yi ZhangWei-Juan Gao
Jun 5, 2019·EBioMedicine·Svetlana LublinskyAlon Friedman
Jun 12, 2019·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Ding NanYining Huang
Oct 23, 2019·Journal of Ethnopharmacology·Fei YinJiehong Yang
Jul 18, 2020·Life Sciences·Qingzhong ZhouDaxiong Feng
Aug 1, 2020·Inflammation·Tiansong YangZhongren Sun
Aug 10, 2020·Scientific Reports·Satchakorn KhamchaiJiraporn Tocharus
Sep 10, 2020·International Journal of Immunopathology and Pharmacology·Xin LiuBaoping Shao
Sep 11, 2020·Journal of Neuroinflammation·Hila IsraelovItzik Cooper
Sep 11, 2020·Journal of Molecular Neuroscience : MN·Xin GuoPeiyuan Lv
Sep 15, 2020·American Journal of Physiology. Endocrinology and Metabolism·Shuangyan YangLili Song